Can a spinal injection restore movement after paralysis?

NCT ID NCT07722962

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This phase 3 trial tests whether an experimental drug called KP-100IT, injected into the spinal fluid, can help people with severe acute spinal cord injuries regain function. Participants, aged 18 to 89 with a complete loss of motor and sensory function (AIS grade A), receive five weekly doses and are followed for 24 weeks. The study measures improvements in spinal injury classification, motor and sensory scores, and the ability to perform daily activities.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an experimental drug called KP-100IT injected into the spinal fluid
What this could lead to
If it works, this could point toward a treatment that helps people with severe spinal cord injuries recover significant movement and sensation.
What could go wrong
This is a small, early-phase trial with only 10 participants, so results may not apply widely. The drug is injected directly into the spine, which carries risks like infection or nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE SPINAL CORD INJURY (SCI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Japan Organization for Occupational Health and Safety Comprehensive Spinal Cord Injuries Center

    Iizuka, Fukuoka, 820-8508, Japan

    Contact Phone: •••-•••-••••

  • Japan Organization for Occupational Health and Safety Hokkaido Spinal Cord Injury Center

    Bibai, Hokkaido, 072-0015, Japan

  • National Hospital Organization Murayama Medical Center

    Musashimurayama, Tokyo, 208-0011, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.